Literature DB >> 9764133

Depression in people with first-episode schizophrenia.

D Addington1, J Addington, S Patten.   

Abstract

BACKGROUND: Depression has been described in people presenting with first-episode schizophrenia, a group at high relative risk of suicide.
METHOD: This was a longitudinal cohort study of 113 people during an acute relapse and 13 having a first episode. Follow-up occurred at three months and at one year. This report compares level of depression in the first episode and in the relapsing group. Levels of depression were assessed using the Calgary Depression Scale for Schizophrenia (CDSS).
RESULTS: The median CDSS score was statistically significantly higher in the first-episode group both during the acute phase and at three month follow-up. At one year the first-episode group continued to have higher levels of depression than the multiple episode group.
CONCLUSIONS: For people with a first episode of schizophrenia, depression is a major problem during the initial acute phase and during the first year of illness. In light of the high risk of suicide in this population, recognition and treatment of depression requires greater attention.

Entities:  

Mesh:

Year:  1998        PMID: 9764133

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  23 in total

Review 1.  Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.

Authors:  Max Birchwood; Zaffer Iqbal; Rachel Upthegrove
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

2.  Negative symptoms and their association with depressive symptoms in the long-term course of schizophrenia.

Authors:  Wolfram An der Heiden; Anne Leber; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-23       Impact factor: 5.270

Review 3.  Guidelines for the Pharmacotherapy of Schizophrenia in Adults.

Authors:  Gary Remington; Donald Addington; William Honer; Zahinoor Ismail; Thomas Raedler; Michael Teehan
Journal:  Can J Psychiatry       Date:  2017-07-13       Impact factor: 4.356

4.  Acute risk of suicide and suicide attempts associated with recent diagnosis of mental disorders: a population-based, propensity score-matched analysis.

Authors:  Jason R Randall; Randy Walld; Greg Finlayson; Jitender Sareen; Patricia J Martens; James M Bolton
Journal:  Can J Psychiatry       Date:  2014-10       Impact factor: 4.356

5.  Depression in the long-term course of schizophrenia.

Authors:  Wolfram an der Heiden; Regina Könnecke; Kurt Maurer; Daniel Ropeter; Heinz Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-06       Impact factor: 5.270

Review 6.  First-episode schizophrenia: a focus on pharmacological treatment and safety considerations.

Authors:  Deanna L Kelly; Robert R Conley; William T Carpenter
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 7.  [Schizophrenia and depression].

Authors:  K Maurer; G Trendler; M Schmidt; W An der Heiden; R Könnecke; H Häfner
Journal:  Nervenarzt       Date:  2006-07       Impact factor: 1.214

8.  Multiple informants in assessing stress and symptoms in adolescents with schizophrenia.

Authors:  Heeyoung Lee; Karen G Schepp
Journal:  Arch Psychiatr Nurs       Date:  2010-08-16       Impact factor: 2.218

Review 9.  Kraepelin and psychotic prodromal conditions.

Authors:  Joachim Klosterkötter; Frauke Schultze-Lutter; Stephan Ruhrmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

10.  Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions?

Authors:  Heinz Häfner; Wolfram an der Heiden; Kurt Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.